Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Institute of Chemistry, University of Duisburg-Essen, Essen, Germany.
Commun Biol. 2021 Sep 14;4(1):1076. doi: 10.1038/s42003-021-02603-2.
Lysine-selective molecular tweezers are promising drug candidates against proteinopathies, viral infection, and bacterial biofilm. Despite demonstration of their efficacy in multiple cellular and animal models, important questions regarding their mechanism of action, including cell penetrance and intracellular distribution, have not been answered to date. The main impediment to answering these questions has been the low intrinsic fluorescence of the main compound tested to date, called CLR01. Here, we address these questions using new fluorescently labeled molecular tweezers derivatives. We show that these compounds are internalized in neurons and astrocytes, at least partially through dynamin-dependent endocytosis. In addition, we demonstrate that the molecular tweezers concentrate rapidly in acidic compartments, primarily lysosomes. Accumulation of molecular tweezers in lysosomes may occur both through the endosomal-lysosomal pathway and via the autophagy-lysosome pathway. Moreover, by visualizing colocalization of molecular tweezers, lysosomes, and tau aggregates we show that lysosomes likely are the main site for the intracellular anti-amyloid activity of molecular tweezers. These findings have important implications for the mechanism of action of molecular tweezers in vivo, explaining how administration of low doses of the compounds achieves high effective concentrations where they are needed, and supporting the development of these compounds as drugs for currently cureless proteinopathies.
赖氨酸选择性分子钳是治疗蛋白质病、病毒感染和细菌生物膜的有前途的药物候选物。尽管在多种细胞和动物模型中证明了它们的疗效,但关于其作用机制的重要问题,包括细胞通透性和细胞内分布,尚未得到解答。迄今为止,回答这些问题的主要障碍是主要测试化合物 CLR01 的固有荧光较低。在这里,我们使用新的荧光标记的分子钳衍生物来解决这些问题。我们表明,这些化合物可以被神经元和星形胶质细胞内化,至少部分是通过网格蛋白依赖性内吞作用。此外,我们证明分子钳在酸性隔室(主要是溶酶体)中迅速积累。分子钳在溶酶体中的积累可能既通过内体溶酶体途径,也通过自噬溶酶体途径发生。此外,通过可视化分子钳、溶酶体和 tau 聚集体的共定位,我们表明溶酶体可能是分子钳在细胞内抗淀粉样活性的主要部位。这些发现对分子钳在体内的作用机制具有重要意义,解释了为什么低剂量给药就能达到所需的高有效浓度,并支持将这些化合物开发为治疗目前尚无治愈方法的蛋白质病的药物。